Form 4: Phreesia COO Evan Roberts Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Phreesia's Chief Operating Officer, Evan Roberts, executed sales of common stock on February 13 and 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Evan Roberts, the Chief Operating Officer of Phreesia, Inc., sold shares of common stock on February 13 and 14, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on July 17, 2024.
- On February 13, 2025, 16,005 shares were sold at a weighted average price of $30.0001, with prices ranging from $30.00 to $30.02.
- On February 14, 2025, 3,586 shares were sold at a weighted average price of $30.128, with prices ranging from $30.00 to $30.41.
- Following these transactions, Roberts directly owns 744,716 shares of Phreesia common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine stock sales under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.
Industry Context
Insider selling is a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares over time while avoiding accusations of trading on material non-public information. The market will likely interpret this as a routine transaction unless the size of the sale is unusually large or coincides with other negative news.
Comparison to Industry Standards
- Comparing this transaction to other similar companies in the healthcare technology sector, insider selling is a fairly common practice.
- For example, executives at Veeva Systems and Cerner (now Oracle Health) have also utilized 10b5-1 plans for regular stock sales.
- The size of the transaction is relatively small compared to the overall market capitalization of Phreesia, suggesting it's unlikely to have a significant impact on the stock price.
Stakeholder Impact
- The impact on shareholders is likely minimal, as the sales are part of a pre-planned trading strategy and represent a small portion of the outstanding shares.
- Employees are unlikely to be directly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 02/13/2025 | Date of first reported transaction: sale of 16,005 shares |
| 02/14/2025 | Date of second reported transaction: sale of 3,586 shares |
| 02/18/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.